Balchem Corporation (NASDAQ:BCPC) Files An 8-K Regulation FD Disclosure

0
Balchem Corporation (NASDAQ:BCPC) Files An 8-K Regulation FD Disclosure

Balchem Corporation (NASDAQ:BCPC) Files An 8-K Regulation FD Disclosure
ITEM 7.01

REGULATION FD DISCLOSURE.

On December 13, 2018, Balchem Corporation (the “Company”) issued a press release announcing a dividend declared by the Company’s Board of Directors on December 12, 2018. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01

Financial Statements and Exhibits.

Exhibit 99.1

Press Release of Balchem Corporation, dated December 13, 2018.

BALCHEM CORP Exhibit
EX-99.1 2 ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Balchem Corporation Announces Dividend New Hampton,…
To view the full exhibit click here

About Balchem Corporation (NASDAQ:BCPC)

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. Its SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, grain-based snacks and cereal-based ingredients. ANH segment provides basic choline chloride, and microencapsulation and chelation technologies-based nutritional products. Specialty Products segment provides ethylene oxide and propylene oxide products. Its Industrial Products segment provides Choline Chloride and methylamines. The Company sells its products through its own sales force, independent distributors and sales agents.